Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells

Molecular Cancer Research

Volumn 6, Issue 12, 2008, Pages 1881-1893

  Xu, Yong ^a   Fang, Fang ^a   Dhar, Sanjit K ^a   Bosch, Antonio ^b   St Clair, William H ^a   Kasarskis, Edward J ^a,b   St Clair, Daret K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION;

ADENOCARCINOMA; CARCINOMA, HEPATOCELLULAR; CELL LINE, TRANSFORMED; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; LUNG; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASMS; PROMOTER REGIONS, GENETIC; PROSTATE; PROSTATIC NEOPLASMS; SP1 TRANSCRIPTION FACTOR; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTIONAL ACTIVATION;

EID: 57749106572     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0253     Document Type: Article

References (48)

1. Fridovich I. The biology of oxygen radicals. Science 1978;201:875-80.
2. Oberley LW, Buettner GB. Role of superoxide dismutase in cancer: a review. Cancer Res 1979;39:1141-9.
3. Oberley LW. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother 2005;59:143-8.
4. Zhao Y, Chaiswing L, Oberley TD, et al. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res 2005;65: 1401-5.
5. Pani G, Colavitti R, Bedogni B, et al. Mitochondrial superoxide dismutase: a promising target for new anticancer therapies. Curr Med Chem 2004;11: 1299-308.
6. Josson S, Xu Y, Fang F, et al. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Oncogene 2006; 25:1554-9.
7. Xu Y, Fang F, St Clair DK, et al. Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1α,25-dihydroxyvitamin D(3) in prostate cancer cells. Mol Cancer Ther 2007;6:2048-56.
8. Matsuda Y, Higashiyama S, Kijima Y, et al. Human liver manganese superoxide dismutase. Purification and crystallization, subunit association and sulfhydryl reactivity. Eur J Biochem 1990;194:713-20.
9. Wan XS, Devalaraja MN, St Clair DK. Molecular structure and organization of the human manganese superoxide dismutase gene. DNA Cell Biol 1994;13: 1127-36.
10. Yeh CC, Wan XS, St Clair DK. Transcriptional regulation of the 5′ proximal promoter of the human manganese superoxide dismutase gene. DNA Cell Biol 1998;17:921-30.
11. Xu Y, Porntadavity S, St Clair DK. Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). Biochem J 2002;362:401-12.
12. Xu Y, Fang F, Dhar SK, et al. The role of a single-stranded nucleotide loop in transcriptional regulation of the human sod2 gene. J Biol Chem 2007;282: 15981-94.
13. Dryer SE, Dryer RL, Autor AP. Enhancement of mitochondrial, cyanide-resistant superoxide dismutase in the livers of rats treated with 2,4-dinitrophenol. J Biol Chem 1980;255:1054-7.
14. Krall J, Bagley AC, Mullenbach GT, et al. Superoxide mediates the toxicity of paraquat for cultured mammalian cells. J Biol Chem 1988;263: 1910-4.
15. Poswig A, Wenk J, Brenneisen P, et al. Adaptive antioxidant response of manganese-superoxide dismutase following repetitive UVA irradiation. J Invest Dermatol 1999;112:13-8.
16. Jones PL, Ping D, Boss JM. Tumor necrosis factor α and interleukin-1β regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-β and NF-κB. Mol Cell Biol 1997;17: 6970-81.
17. Xu Y, Kiningham KK, Devalaraja MN, et al. An intronic NF-κB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-α and interleukin-1β. DNA Cell Biol 1999;18:709-22.
18. Dhar SK, Lynn BC, Daosukho C, St Clair DK. Identification of nucleophosmin as an NF-κB co-activator for the induction of the human SOD2 gene. J Biol Chem 2004;279:28209-19.
19. Xu Y, Krishnan A, Wan XS, et al. Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells. Oncogene 1999;18:93-102.
20. Martin RC, Hughes K, Doll MA, et al. Method for determination of (-102C>T) single nucleotide polymorphism in the human manganese superoxide dismutase promoter. BMC Genet 2004;5:33.
21. Duan C, Clemmons DR. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J Biol Chem 1995;270: 24844-51.
22. Benhar M, Engelberg D, Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 2002;3:420-5.
23. Oberley LW, Oberley TD. In: Free radicals, aging and degenerative diseases. Johnson JE, Jr., Harman D, Miquel J, editors. New York: Alan R. Liss; 1986. p.325-72.
24. Bravard A, Sabatier L, Hoffschir F, et al. SOD2: a new type of tumor-suppressor gene? Int J cancer 1992;51:476-80.
25. St Clair DK, Zhao Y, Chaiswing L, Oberley TD. Modulat ion of skin tumorigenesis by SOD. Biomed Pharmacother 2005;59:209-14.
26. St Clair DK, Holland JC. Complementary DNA encoding human colon cancer manganese superoxide dismutase and the expression of its gene in human cells. Cancer Res 1991;51:939-43.
27. Huang Y, He T, Domann FE. Decreased expression of manganese superoxide dismutase in transformed cells is associated with increased cytosine methylation of the SOD2 gene. DNA Cell Biol 1999;18:643-52.
28. Hitchler MJ, Wikainapakul K, Yu L, et al. Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells. Epigenetics 2006;1:163-71.
29. Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999;59:602-6.
30. Nakano T, Oka K, Taniguchi N. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. Cancer Res 1996;56:2771-5.
31. Landriscina M, Remiddi F, Ria F, et al. The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin. Br J Cancer 1996;74:1877-85.
32. Janssen AM, Bosman CB, Sier CF, et al. Superoxide dismutases in relation to the overall survival of colorectal cancer patients. Br J Cancer 1998; 78:1051-7.
33. Chung-man Ho J, Zheng S, Comhair SA, et al. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 2001; 61:8578-85.
34. Ria F, Landriscina M, Remiddi F, et al. The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications. Br J Cancer 2001;84:529-34.
35. Zhao Y, Chaiswing L, Velez JM, et al. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 2005; 65:3745-50.
36. Greenberger JS, Epperly MW. Review. Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization. In Vivo 2007;21:141-6.
37. Eckert D, Buhl S, Weber S, et al. The AP-2 family of transcription factors. Genome Biol 2005;6:246.
38. Getman DK, Mutero A, Inoue K, Taylor P. Transcription factor repression and activation of the human acetylcholinesterase gene. J Biol Chem 1995;270: 23511-9.
39. Chen TT, Wu RL, Castro-Munozledo F, Sun TT. Regulation of K3 keratin gene transcription by Sp1 and AP-2 in differentiating rabbit corneal epithelial cells. Mol Cell Biol 1997;17:3056-64.
40. Batsché E, Muchardt C, Behrens J, et al. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 1998;18:3647-58.
41. Wajapeyee N, Somasundaram K. Cell cycle arrest and apoptosis induction by activator protein 2α (AP-2α) and the role of p53 and p21WAF1/CIP1 in AP-2α-mediated growth inhibition. J Biol Chem 2003;278:52093-101.
42. Liu H, Tan BC, Tseng KH, et al. Nucleophosmin acts as a novel AP2α-binding transcriptional corepressor during cell differentiation. EMBO Rep 2007; 8:394-400.
43. Zhang J, Hagopian-Donaldson S, Serbedzija G, et al. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 1996;381: 238-41.
44. Pellikainen JM, Kosma VM. Activator protein-2 in carcinogenesis with a special reference to breast cancer - a mini review. Int J Cancer 2007;120: 2061-7.
45. Ruiz M, Pettaway C, Song R, et al. Activator protein 2α inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells. Cancer Res 2004;64:631-8.
46. McPherson LA, Loktev AV, Weigel RJ. Tumor suppressor activity of AP2α mediated through a direct interaction with p53. J Biol Chem 2002;277: 45028-33.
47. Zeng YX, Somasundaram K, el-Deiry WS. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat Genet 1997;15:78-82.
48. Decary S, Decesse JT, Ogryzko V, et al. The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. Mol Cell Biol 2002;22:7877-88.